Arthur Taveras
CIK 1830901 · Chief Scientific Officer · last filed 2024-10-08
Arthur Taveras is a Chief Scientific Officer who has filed 13 SEC Form 4 insider transactions across 1 company since 2020. The most recent filing, for XFOR, was dated Oct 8, 2024. Across all open-market trades the lifetime net is −$121.0K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.55M
1
13
-$121.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XFOR | Chief Scientific Officer | 388,026 | $4.00 | $1.55M | -$121.0K | 13 | 2024-10-08 |
Recent Filings
13 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-10-08 | XFOR | Mixed | +153,725 | -$43.3K | EDGAR |
| 2024-03-11 | XFOR | Sell (S) | −14,235 | -$12.6K | EDGAR |
| 2024-02-16 | XFOR | Grant (A) | — | $0 | EDGAR |
| 2024-02-12 | XFOR | Sell (S) | −787 | -$793 | EDGAR |
| 2023-11-03 | XFOR | Sell (S) | −67,695 | -$49.4K | EDGAR |
| 2023-11-02 | XFOR | Grant (A) | +230,645 | $0 | EDGAR |
| 2023-03-13 | XFOR | Sell (S) | −16,806 | -$14.1K | EDGAR |
| 2023-02-15 | XFOR | Sell (S) | −928 | -$863 | EDGAR |
| 2022-11-09 | XFOR | Grant (A) | — | $0 | EDGAR |
| 2022-03-01 | XFOR | Grant (A) | +97,000 | $0 | EDGAR |